Us Esketamine Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Esketamine Market was valued at USD 2.5 Billion in 2022 and is projected to reach USD 7.1 Billion by 2030, growing at a CAGR of 17.0% from 2024 to 2030.
The U.S. esketamine market has experienced significant growth, driven by its approval as a treatment for depression resistant to other therapies. Since its introduction in 2019, esketamine, marketed as Spravato by Johnson & Johnson, has offered a novel approach for patients unresponsive to traditional antidepressants. Administered as a nasal spray under strict medical supervision, it provides rapid relief from depressive symptoms, often within hours. This quick onset is particularly beneficial for individuals with severe depression or suicidal ideation. The drug's annual sales are expected to exceed $1 billion, with projections potentially reaching $5 billion. citeturn0news24
The rise in esketamine's popularity has also led to the expansion of specialized ketamine clinics across the U.S. These clinics offer both on-site and online therapy sessions, catering to various mental health conditions such as depression, anxiety, and PTSD. The U.S. ketamine clinics market was valued at approximately $3.41 billion in 2023 and is projected to reach $6.90 billion by 2030, growing at a CAGR of 10.60%. citeturn0search0 This growth is attributed to the increasing recognition of ketamine's therapeutic potential and the rising prevalence of mental health disorders.
Despite its benefits, esketamine treatment comes with challenges. Patients are required to self-administer the nasal spray under medical supervision in certified health facilities and remain under observation for at least two hours due to potential side effects like sedation and dissociation. Common side effects reported include dizziness, nausea, and a feeling of disconnection from one's body. citeturn0search3 Additionally, the treatment's cost, ranging from $4,720 to $6,785 per month, excluding associated medical fees, has raised concerns about accessibility and insurance coverage. citeturn0search5
Personal experiences with esketamine vary. Some patients report significant improvements in mood and functionality, describing a lifting of the "heavy blanket" of depression. Others experience side effects such as nausea, dizziness, and fatigue post-treatment. citeturn0search8 As the esketamine market continues to evolve, ongoing research and patient experiences will play crucial roles in shaping its future applications and accessibility.
Get an In-Depth Research Analysis of the Global Esketamine Market Size And Forecast [2025-2032]
Merck
Medkoo
Endo International
Janssen Pharmaceutica
PFIZER
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Esketamine Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Esketamine Market
Intranasal Esketamine
Intravenous Esketamine
Treatment-Resistant Depression (TRD)
Major Depressive Disorder (MDD)
Post-Traumatic Stress Disorder (PTSD)
Suicidal Ideation
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Hospitals
Specialty Clinics
Homecare Settings
Adults (18-65 years)
Elderly (65 years and above)
Pediatric Population (under 18 years)
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Esketamine Market Research Analysis
1. Introduction of the Global Esketamine Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Esketamine Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Esketamine Market, By Type
6. Global Esketamine Market, By Application
7. Global Esketamine Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Esketamine Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/